Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: iana5252 on May 07, 2015, 09:33:51 am

Title: High Hep C Cure Rate for Daclatasvir and Sovaldi in Those With HIV
Post by: iana5252 on May 07, 2015, 09:33:51 am
New treatment option coming soon for those living with HCV and HIV.

Bristol-Myers Squibb’s daclatasvir and Gilead Sciences’ Sovaldi (sofosbuvir) cured 97 percent of hepatitis C virus (HCV) among those with genotypes 1 through 4 of the virus who are coinfected with HIV. Researchers presented findings from the Phase III ALLY-2 trial, which included people with cirrhosis, at the 50th International Liver Congress in Vienna, Austria.